Clear cell degeneration associated with endometriosis of abdominal wall after cesarean section: A case report and systematic review of literature.
abdominal wall endometriosis
cesarean section
clear cell borderline tumor
clear cell carcinoma
clear cell degeneration
Journal
The journal of obstetrics and gynaecology research
ISSN: 1447-0756
Titre abrégé: J Obstet Gynaecol Res
Pays: Australia
ID NLM: 9612761
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
revised:
11
10
2020
received:
02
07
2020
accepted:
17
12
2020
pubmed:
15
1
2021
medline:
25
5
2021
entrez:
14
1
2021
Statut:
ppublish
Résumé
The scar of cesarean section (CS) is the most common site of abdominal wall endometriosis (AWE), whose tumor degeneration has been reported in an increasing number of cases; the most frequent histological type is clear cell carcinoma (CCC). We conducted a systematic research of the literature, collecting data regarding the evidence on tumor degeneration from AWE after CS. Moreover, we reported a case of clear cell borderline tumor (CCBT) originating from AWE. We included data of 37 patients with diagnosis of CCC. The average time between the last CS and the diagnosis of CCC was around 15 years. Overall, 26.0% and 73.9% patients received exclusive local abdominal resection of the lesion and additional surgery, respectively. Lymph nodes involvement was detected in 26.0 % patients and adjuvant chemotherapy was administered in 52.0 % cases. During follow-up period, 15.2% patients died of disease, 32.6% had no evidence of disease, and 17.4% recurred. We diagnosed a CCBT arose in a patients with AWE and a personal history of several surgical procedures for endometriosis, a CS and a subsequent transverse laparotomy. We performed an open bilateral ovariectomy and a large excision of the endometriotic abdominal lesion. Tumor degeneration from AWE seems to be a real occurrence with an increasing number of events. Considering the lack of risk factors and diagnostic instruments for tumor degeneration, the removal of AWE localization could be advisable, even though there was long average time between the trigger surgery and the tumor finding.
Types de publication
Case Reports
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1243-1252Informations de copyright
© 2021 Japan Society of Obstetrics and Gynecology.
Références
Giudice LC. Endometriosis. N Engl J Med 2010; 362: 2389-2398.
Barra F, Scala C, Mais V, Guerriero S, Ferrero S. Investigational drugs for the treatment of endometriosis, an update on recent developments. Expert Opin Investig Drugs 2018; 27: 445-458.
Ciravolo G, Ferrari F, Zizioli V et al. Laparoscopic management of a large urethral leiomyoma. Int Urogynecol J 2019; 30: 1211-1213.
Donarini P, Ciravolo G, Rampinelli F, Odicino F, Ferrari FG, Sartori E. Parametrial endometriosis with ureteral involvement: A case report of a conservative approach without ureteral resection. J Endometr Pelvic Pain Disord. 2018; 10: 222-223.
La Rosa VL, De Franciscis P, Barra F et al. Quality of life in women with endometriosis: A narrative overview. Minerva Med. 2020; 111: 68-78.
Fukunaga M. Uterus-like mass in the uterine cervix: Superficial cervical endometriosis with florid smooth muscle metaplasia? Virchows Arch. 2001; 438: 302-305.
La Rosa VL, Barra F, Chiofalo B et al. An overview on the relationship between endometriosis and infertility: the impact on sexuality and psychological well-being. J Psychosom Obstet Gynecol. 2020; 41: 93-97.
Kurman R, Carcangiu M, Herrington C, Young R. World Health Organization classification of tumours classification of tumours of female reproductive organs. 4th ed. 2014.
Barra F, Scala C, Ferrero S. Current understanding on pharmacokinetics, clinical efficacy and safety of progestins for treating pain associated to endometriosis. Expert Opin Drug Metab Toxicol 2018; 14: 399-415.
Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstet Gynecol Clin North Am 1997; 24: 235-258.
Moioli M, Barra F, Maramai M et al. Mucinous ovarian cancer: current therapeutic targets, preclinical progress, and experimental drugs. Expert Opin Investig Drugs. 2019; 28: 1025-1029.
Laganà AS, Garzon S, Götte M et al. The pathogenesis of endometriosis: Molecular and cell biology insights. Int J Mol Sci 2019; 20: 5615.
Laganà AS, Vitale SG, Salmeri FM et al. Unus pro omnibus, omnes pro uno: A novel, evidence-based, unifying theory for the pathogenesis of endometriosis. Med Hypotheses 2017; 103: 10-20.
Taniguchi F. New knowledge and insights about the malignant transformation of endometriosis. J Obstet Gynaecol Res 2017; 43: 1093-1100.
Wilbur MA, Shih I, Segars JH, Fader AN. Cancer implications for patients with endometriosis. Semin Reprod Med 2017; 35: 110-116.
Laganà A, Colonese F, Colonese E et al. Cytogenetic analysis of epithelial ovarian cancer's stem cells: An overview on new diagnostic and therapeutic perspectives. Eur J Gynaecol Oncol 2015; 36: 495-505.
Herreros-Villanueva M, Chen CC, Tsai EM, Er TK. Endometriosis-associated ovarian cancer: What have we learned so far? Clin Chim Acta 2019; 493: 63-72.
Maeda D, Shih IM. Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms. Adv Anat Pathol 2013; 20: 45-52.
Sampson J. Endometrial carcinoma of the ovary, arising in endometrial tissue in that organ. Arch Surg 1925; 10: 1.
Koninckx PR, Muyldermans M, Moerman P, Meuleman C, Deprest J, Cornillie F. CA 125 concentrations in ovarian “chocolate” cyst fluid can differentiate an endometriotic cyst from a cystic corpus luteum. Hum Reprod 1992; 7: 1314-1317.
Barra F, Scala C, Biscaldi E et al. Ureteral endometriosis: A systematic review of epidemiology, pathogenesis, diagnosis, treatment, risk of malignant transformation and fertility. Hum Reprod Update 2018; 24: 710-730.
Benoit L, Arnould L, Cheynel N et al. Malignant extraovarian endometriosis: A review. Eur J Surg Oncol 2006; 32: 6-11.
Soleymani Majd H, Ferrari F, Manek S et al. Diaphragmatic peritonectomy vs. full thickness resection with pleurectomy during visceral-peritoneal Debulking (VPD) in 100 consecutive patients with stage IIIC-IV ovarian cancer: A surgical-histological analysis. Gynecol Oncol 2016; 140: 430-435.
Tozzi R, Soleymani Majd H, Campanile RG, Ferrari F. Feasibility of laparoscopic diaphragmatic peritonectomy during visceral-peritoneal debulking in patients with stage IIIC-IV ovarian cancer. J Gynecol Oncol 2020; 31: e71.
Ferrero S, Evangelisti G, Barra F. Current and emerging treatment options for endometriosis. Expert Opin Pharmacother. 2018; 19: 1109-1125.
Soleymani majd H, Ferrari F, Gubbala K, Campanile RG, Tozzi R. Latest developments and techniques in gynaecological oncology surgery. Curr Opin Obstet Gynecol 2015; 27: 291-296.
Zhang P, Sun Y, Zhang C et al. Cesarean scar endometriosis: Presentation of 198 cases and literature review. BMC Womens Health 2019; 19: 1-6.
Bats AS, Zafrani Y, Pautier P, Duvillard P, Morice P. Malignant transformation of abdominal wall endometriosis to clear cell carcinoma: Case report and review of the literature. Fertil Steril 2008; 90: 1197.e13-1197.e16.
Mihailovici A, Rottenstreich M, Kovel S, Wassermann I, Smorgick N, Vaknin Z. Endometriosis-associated malignant transformation in abdominal surgical scar. Medicine (United States) 2017; 96: 1-5.
Van Gorp T, Amant F, Neven P, Vergote I, Moerman P. Endometriosis and the development of malignant tumours of the pelvis. A review of literature. Best Pract Res Clin Obstet Gynaecol 2004; 18: 349-371.
Ferrandina G, Palluzzi E, Fanfani F et al. Endometriosis-associated clear cell carcinoma arising in caesarean section scar: A case report and review of the literature. World J Surg Oncol 2016; 14: 300.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ 2009; 339: 332-336.
Williams C, Petignat P, Belisle A, Drouin P. Primary abdominal wall clear cell carcinoma: Case report and review of literature. Anticancer Res. 2009; 29: 1591-1593.
Bourdel N, Durand M, Gimbergues P, Dauplat J, Canis M. Exclusive nodal recurrence after treatment of degenerated parietal endometriosis. Fertil Steril. 2010; 93: 2074.e1-2074.e6.
Yan Y, Li L, Guo J, Zheng Y, Liu Q. Malignant transformation of an endometriotic lesion derived from an abdominal wall scar. Int J Gynecol Obstet. 2011; 115: 202-203.
Mert I, Semaan A, Kim S, Ali-Fehmi R, Morris RT. Clear cell carcinoma arising in the abdominal wall: Two case reports and literature review. Am J Obstet Gynecol. 2012; 207: e7.
Shalin SC, Haws AL, Carter DG, Zarrin-Khameh N. Clear cell adenocarcinoma arising from endometriosis in abdominal wall cesarean section scar: A case report and review of the literature. J Cutan Pathol. 2012; 39: 1035-1041.
Sawazaki H, Goto H, Takao N, Taki Y, Takeuchi H. Clear cell adenocarcinoma arising from abdominal wall endometriosis mimicking urachal tumor. Urology. 2012; 79: e84-e85.
Li X, Yang J, Cao D, Lang J, Chen J, Shen K. Clear-cell carcinoma of the abdominal wall after cesarean delivery. Obstet Gynecol. 2012; 120: 445-448.
Liu H, Leng J, Lang J, Cui Q. Clear cell carcinoma arising from abdominal wall endometriosis: A unique case with bladder and lymph node metastasis. World J Surg Oncol. 2014; 12: 2-7.
Heller DS, Houck K, Edward S, Lee MSG. Clear Cell Adenocarcinoma of the Abdominal Wall: A Case Report. J Reprod Med 2014; 59: 330-332.
Dobrosz Z, Paleń P, Stojko R, Właszczuk P, Anna Niesłuchowska-Hoxha IP-K. Clear Cell Carcinoma Derived From an Endometriosis Focus in a Scar After a Caesarean Section-A Case Report and Literature Review. Ginekol Pol. 2014; 85: 792-795.
Hitti IF, Glasberg SS, Lubicz S. Clear cell carcinoma arising in extraovarian endometriosis: Report of three cases and review of the literature. Gynecol Oncol. 1990; 39: 314-320.
Ijichi S, Mori T, Suganuma I et al. Clear Cell Carcinoma Arising from Cesarean Section Scar Endometriosis: Case Report and Review of the Literature. Case Rep Obstet Gynecol. 2014; 2014: 1-5.
Aust S, Tiringer D, Grimm C, Stani J, Langer M. Therapy of a clear cell adenocarcinoma of unknown primary arising in the abdominal wall after cesarean section and after hysterectomy. Wien Klin Wochenschr. 2015; 127: 62-64.
Maria Paula Ruiz, Darryl Lewis Wallace and MTC. Transformation of Abdominal Wall Endometriosis to Clear Cell Carcinoma Maria. Case Rep Obstet Gynecol. 2015; 2015: 12374.
Chun-Jui Wei S-HH. Clear cell carcinoma arising from scar endometriosis: A case report and literature review. Tzu Chi Med J. 2017; 29: 55-58.
Ewa K, Marianna B, Mateusz W, Rafał G, Dawid M. Clear Cell Carcinoma of the abdominal wall. Pol Prz Chir Polish J Surg. 2017; 89: 40-43.
Marques C, Silva TS, Dias MF. Clear cell carcinoma arising from abdominal wall endometriosis - Brief report and review of the literature. Gynecol Oncol Reports. 2017; 20: 78-80.
Gentile JK de A, Migliore R, Kistenmacker FJN et al. Malignant transformation of abdominal wall endometriosis to clear cell carcinoma: Case report. Sao Paulo Med J. 2018; 136: 586-590.
Lai YL, Hsu HC, Kuo KT, Chen YL, Chen CA, Cheng WF. Clear cell carcinoma of the abdominal wall as a rare complication of general obstetric and gynecologic surgeries: 15 years of experience at a large academic institution. Int J Environ Res Public Health. 2019; 16.
Lopes A, Anton C, Slomovitz BM, Accardo De Mattos L, Marino Carvalho F. Clear cell carcinoma arising from abdominal wall endometrioma after cesarean section. Int J Gynecol Cancer. 2019; 29: 1332-1335.
Rivera Rolon M del M, Allen D, Richardson G, Clement C. Abdominal Wall Clear Cell Carcinoma: Case Report of a Rare Event with Potential Diagnostic Difficulties. Case Rep Pathol. 2019; 2019: 1-7.
Miller DM, Schouls JJ, Ehlen TG. Clear cell carcinoma arising in extragonadal endometriosis in a caesarean section scar during pregnancy. Gynecol Oncol. 1998; 70: 127-130.
Park SW, Hong SM. Wu HG HS. Clear cell carcinoma arising in a cesarean section scar endometriosis: a case report. J Korean Med Sci. 1999; 14: 217-219.
Li J-Y, Chen Y-J, Wu Y-C et al. Two- and three-dimensional Doppler ultrasound analysis of abdominal wall clear cell carcinoma. Ultrasound Obstet Gynecol. 2003; 22: 98-100.
Alberto VO, Lynch M, Labbei FN, Jeffers M. Primary abdominal wall clear cell carcinoma arising in a Caesarean section scar endometriosis. Ir J Med Sci. 2006; 175: 69-71.
Vanessa N, Harry MBBS, MRCOG, Smruta Shanbhag, MBBS, MRCOG, Matthew Lyall, MBchB, Gordon V. Narayansingh, FRCOG, and David E. Parkin, MD F. Isolated Clear Cell Adenocarcinoma in Scar Endometriosis Mimicking an Incisional Hernia. Obstet Gynecol. 2007; 110: 469-471.
Razzouk K, Roman H, Chanavaz-Lacheray I, Scotté M, Verspyck E, Marpeau L. Mixed clear cell and endometrioid carcinoma arising in parietal endometriosis. Gynecol Obstet Invest. 2007; 63: 140-142.
Rust MM, Susa J, Naylor R, Cavuoti D. Clear cell carcinoma in a background of endometriosis: Case report of a finding in a midline abdominal scar 5 years after a total abdominal hysterectomy. Acta Cytol. 2008; 52: 475-480.
Ishida GM, Motoyama T, Watanabe T, Emura I. Clear Cell Carcinoma Arising in a Cesarean Section Scar: Report of a Case with Fine Needle Aspiration Cytology. Acta Cytol. 2003; 47: 1095-1098.
Wyrens R, Randall L. Endometriosis in scars. Am J Surg. 1942; 56: 397-403.
Leiserowitz G, Gumbs J, Oi R et al. Endometriosis-related malignancies. Int J Gynecol Cancer. 2003; 13: 466-471.
Ji W, Wu J, Cheng J, Di W. Serous adenocarcinoma arising from endometriosis in cesarean section abdominal wall scar: A case report and literature review. Int J Clin Exp Pathol. 2017; 10: 7534-7541.
Zhao C, Wu LSF, Barner R. Pathogenesis of ovarian clear cell adenofibroma, atypical proliferative (borderline) tumor, and carcinoma: Clinicopathologic features of tumors with endometriosis or adenofibromatous components support two related pathways of tumor development. J Cancer. 2011; 2: 94-106.
Tognon G, Carnazza M, Ragnoli M et al. Prognostic factors in early-stage ovarian cancer. Ecancermedicalscience. 2013; 7.
Kleebkaow P, Aue-aungkul A, Temtanakitpaisan A, Kietpeerakool C. Borderline Clear Cell Adenofibroma of the Ovary. Case Rep Pathol. 2017; 2017: 1-4.
Tozzi R, Traill Z, Garruto Campanile R et al. Porta hepatis peritonectomy and hepato-celiac lymphadenectomy in patients with stage IIIC-IV ovarian cancer: Diagnostic pathway, surgical technique and outcomes. Gynecol Oncol. 2016; 143: 35-39.
Tozzi R, Ferrari F, Nieuwstad J, Campanile RG, Soleymani Majd H. Tozzi classification of diaphragmatic surgery in patients with stage IIIC-IV ovarian cancer based on surgical findings and complexity. J Gynecol Oncol. 2020; 31: e14.
Soleymani majd H, Ismail L, Hardern K, Ferrari F, Kehoe S. Comparison of survival outcome of patients with primary peritoneal and fallopian tube carcinoma treated with neoadjuvant chemotherapy versus primary debulking surgery. J Obstet Gynaecol (Lahore). 2017; 37: 89-92.
Tozzi R, Giannice R, Cianci S et al. Neo-adjuvant chemotherapy does not increase the rate of complete resection and does not significantly reduce the morbidity of Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancer. Gynecol Oncol. 2015; 138.
Gadducci A, Tana R, Landoni F et al. Analysis of failures and clinical outcome of advanced epithelial ovarian cancer in patients with microscopic residual disease at second-look reassessment following primary cytoreductive surgery and first-line platinum-based chemotherapy. Eur J Gynaecol Oncol. 2013; 34.
Laganà AS, Sofo V, Vitale SG, Triolo O. Epithelial ovarian cancer inherent resistance: May the pleiotropic interaction between reduced immunosurveillance and drug-resistant cells play a key role? Gynecol Oncol Reports. 2016; 18: 57-58.